NOURIANZ 20 mg/1
istradefylline · TABLET, FILM COATED · Kyowa Kirin, Inc.
Nourianz (istradefylline) is an oral tablet used to reduce "off" episodes in people with Parkinson's disease who are taking levodopa. It works by blocking adenosine receptors in the brain to help improve movement and motor control.
Key Facts
- Brand Name
- NOURIANZ
- Generic Name
- istradefylline
- NDC Code (Product)
42747-602- Manufacturer
- Kyowa Kirin, Inc.
- Strength
- 20 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA022075
- Marketing Start
- 08/27/2019
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Frequently Asked Questions
What is NOURIANZ used for?
Nourianz (istradefylline) is an oral tablet used to reduce "off" episodes in people with Parkinson's disease who are taking levodopa. It works by blocking adenosine receptors in the brain to help improve movement and motor control.
Is NOURIANZ a controlled substance?
NOURIANZ is not classified as a controlled substance by the DEA.
What is the generic name for NOURIANZ?
The generic name for NOURIANZ is istradefylline. There are no other listed brand versions of istradefylline.
What is the NDC code for NOURIANZ 20 mg/1?
The NDC (National Drug Code) for NOURIANZ 20 mg/1 is 42747-602, listed by Kyowa Kirin, Inc..
Other NOURIANZ Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)